Literature DB >> 9317065

Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?

K K Ellis1, M Oehlke, M Helfand, D Lieberman.   

Abstract

OBJECTIVES: The purpose of this study was to examine the theories that underlie the clinical decision to perform endoscopy in patients with symptoms of gastroesophageal reflux disease (GERD). Physicians reported that they use endoscopic findings to modify medical treatment of GERD. This study was undertaken to test this hypothesis in clinical practice.
METHODS: A consortium of community specialists in gastrointestinal disease was formed. Physicians completed a database on patients undergoing elective endoscopy for symptoms of GERD, which includes symptom severity, endoscopic findings, and medical treatment before and after endoscopy. An increase in medical treatment was defined as an increase in acid suppression therapy, and/or the addition of a promotility drug, and/or referral for surgery.
RESULTS: Data were collected prospectively over 6 months on 664 patients with symptoms of GERD, and complete data were available on 598 patients. Barrett's esophagus or active esophagitis (erythema, erosions, or ulceration) was present in 374 patients. Of these patients, 74% had an increase in therapy after endoscopy; for only 5% did therapy decrease. In contrast, among 224 patients with a normal-appearing esophagus, 35% had an increase in treatment and 65% had either a decrease in treatment or no change. In most cases, the increase in treatment was due to persistence of symptoms or because of endoscopic findings in the stomach or duodenum. The differences in treatment changes between the two groups was highly significant (p < 0.0001).
CONCLUSION: The results support the theory that physicians often use endoscopic results to tailor medical therapy in patients with symptoms of GERD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317065

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.

Authors:  Joan Monés
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Evidence based case reports. Undergraduates in Cork have to submit them during their course.

Authors:  I J Perry
Journal:  BMJ       Date:  1998-11-14

4.  Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.

Authors:  N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 5.  Endoscopic evaluation of gastro-esophageal reflux disease.

Authors:  D Armstrong
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun

Review 6.  Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.

Authors:  G N Tytgat
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.